
Grifols, S.A. GRFS
$ 9.25
1.49%
Annual report 2024
added 01-24-2026
Grifols, S.A. ROE Ratio 2011-2026 | GRFS
Annual ROE Ratio Grifols, S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 9.2 | 14.4 | 18.25 | 20.09 | 23.63 | 25.72 | 26.75 | 30.99 | 27.68 | 6.6 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 30.99 | 6.6 | 20.33 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Adagene
ADAG
|
-66.16 | $ 2.62 | 28.82 % | $ 147 M | ||
|
GlaxoSmithKline plc
GSK
|
27.63 | $ 48.98 | 0.68 % | $ 173 B | ||
|
Acorda Therapeutics
ACOR
|
160.08 | - | -24.86 % | $ 820 K | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-36.22 | $ 3.51 | 7.34 % | $ 8.45 B | ||
|
AgeX Therapeutics
AGE
|
-270.67 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-40.17 | - | - | $ 1.01 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
21.78 | $ 25.92 | -0.86 % | $ 1.26 B | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Galapagos NV
GLPG
|
-11.44 | $ 34.61 | 0.61 % | $ 2.69 B | ||
|
Ultragenyx Pharmaceutical
RARE
|
-222.95 | $ 24.45 | 4.49 % | $ 2.21 B | ||
|
Aptose Biosciences
APTO
|
559.76 | - | -45.71 % | $ 1.2 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Athira Pharma
ATHA
|
-216.19 | - | - | $ 269 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
BioLineRx Ltd.
BLRX
|
-136.27 | $ 3.1 | 4.49 % | $ 908 M | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
BioNTech SE
BNTX
|
1.11 | $ 116.27 | -1.86 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Ascendis Pharma A/S
ASND
|
-43.41 | $ 235.41 | 2.95 % | $ 5 B | ||
|
BioXcel Therapeutics
BTAI
|
64.02 | $ 1.84 | 1.66 % | $ 4.66 M | ||
|
Burford Capital Limited
BUR
|
10.1 | $ 9.74 | -1.37 % | $ 1.55 B | ||
|
ARCA biopharma
ABIO
|
-21.9 | - | 1052.0 % | $ 415 M | ||
|
Aytu BioScience
AYTU
|
-71.51 | $ 2.66 | -1.85 % | $ 16.7 M | ||
|
Acasti Pharma
ACST
|
-14.36 | - | 4.01 % | $ 150 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-0.35 | $ 67.49 | -3.02 % | $ 9.03 B | ||
|
Brickell Biotech
BBI
|
-57.34 | - | -5.38 % | $ 6.06 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-144.96 | $ 4.51 | 8.41 % | $ 9.81 B | ||
|
BeiGene, Ltd.
BGNE
|
-19.35 | - | 0.49 % | $ 251 B | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-288.19 | - | -15.15 % | $ 60.3 M | ||
|
AIkido Pharma
AIKI
|
-36.89 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
156.54 | - | 2.71 % | $ 14 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
-1239.35 | - | -9.72 % | $ 5.89 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
-51.87 | - | 4.14 % | $ 49.1 M | ||
|
Coherus BioSciences
CHRS
|
122.99 | $ 2.04 | 28.3 % | $ 192 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Biogen
BIIB
|
9.76 | $ 171.89 | -1.1 % | $ 25 B | ||
|
Bio-Path Holdings
BPTH
|
-3645.8 | - | - | $ 100 K | ||
|
BioVie
BIVI
|
-92.27 | $ 1.2 | -3.7 % | $ 1.77 M |